NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









August Bioservices

August Bioservices

Private
Nashville, TennesseeHealthcare & Life Scienceshttps://www.augustbio.com

Last Round

Grant

Oct 20, 2023

Total Funding Raised

$89.6M

Company Overview

August Bioservices is a healthcare company offering contract development and manufacturing services that support drug discovery, pharmaceutical development, and clinical manufacturing for the pharmaceutical and biotechnology industries.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Clinical Trials, Drug Discovery, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOsterile injectable manufacturingaseptic fill/finishfill/finish servicesinjectable drug manufacturingpharmaceutical manufacturinglyophilization servicesformulation developmentanalytical servicesprocess developmentclinical trial servicesvial fillingsyringe fillingpharma supply chaindrug discovery support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

August Bioservices Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

August Bioservices Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantOct 20, 2023
Series BDec 1, 2022
Series A ExtensionMay 27, 2021
Series AJul 16, 2020

Key People

Founding team and executive leadership

Mats Bjoerkman

Chief Financial Officer

Executive Team

Michael Scribner

Chief Operating Officer

Executive Team

August Bioservices Investors

Notable investors and investment history

InvestorRounds
Oak HC/FTSeries A, Series B, Series A Extension
Tennessee Department of Economic and Community DevelopmentGrant
Polaris PartnersSeries B, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 18, 2026

    CEO named Healthcare Technology CEO of the Year.

  • Oct 10, 2025

    Investing significant capital in a two-phase expansion project and new facility construction.

August Bioservices Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

August Bioservices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about August Bioservices's valuation, stock price, and market status.

Firmographic Details

HeadquartersNashville, Tennessee
Employee Range174
Year Founded2017
Last FundingOct 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.